This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
the relative risks of Caesarean delivery associated with induction for both nulliparous and multiparous women with either a favourable or unfavourable cervix; the relative risk of Caesarean delivery associated with spontaneous labour at 39, 40, 41 and 42 weeks; the probability of meconium happening at 39 weeks, and the relative risk of meconium at weeks 40, 41 and 42; the probability of meconium aspiration syndrome if meconium happened; the overall probability of spontaneous labour within 1 week, both in the case of a favourable or unfavourable cervix, during the pregnancy weeks considered at analysis; the overall probability that an unfavourable cervix became favourable within 1 week, during the pregnancy weeks considered at analysis; the probability of having an abnormal antenatal testing; the probability of foetal death at 39, 40 and 41 weeks; and the probability of the Caesarean delivery of a foetal death.
Study designs and other criteria for inclusion in the review
The authors did not report that specific study designs were considered for inclusion in the review. Most of the studies were not described. One of the included studies was a case-control study.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
At least 17 studies were included in the review.
Methods of combining primary studies
The method used to combine the primary studies was not reported, but it seems to have been a narrative method.
Investigation of differences between primary studies
The authors reported ranges of values, which were obtained from the review of the literature, for the estimates reported. However, they did not provide any explanations for the differences obtained.
Results of the review
The probability of having a Caesarean delivery at 39 weeks associated with spontaneous labour was 12.8% for nulliparous women and 3.8% for multiparous women.
The relative risk of Caesarean delivery associated with induction was 1.4 for nulliparous women with a favourable cervix, 2.3 for nulliparous women with an unfavourable cervix, 1.1 for multiparous women with a favourable cervix, and 2.2 for multiparous women with an unfavourable cervix.
The relative risk of Caesarean delivery associated with spontaneous labour was 1.0 at 39 weeks, 1.1 at 40 weeks, 1.3 at 41 weeks, and 1.5 at 42 weeks.
The probability of meconium happening was 12.2% at 39 weeks, 1.4% at 40 weeks, 1.8% at 41 weeks, and 2.3% at 42 weeks.
The probability of meconium aspiration syndrome if meconium happened was 2.4%.
The probability that a spontaneous labour happened within 1 week was 70% in the case of a favourable cervix, and 45% in the case of an unfavourable cervix.
The probability that an unfavourable cervix became favourable within 1 week was 15%.
The probability of having an abnormal antenatal testing was 3.6%.
The probability of foetal death was 0.05% at 39 weeks, 0.09% at 40 weeks, and 0.12% at 41 weeks.
The probability of the Caesarean delivery of a foetal death was 0%.
Methods used to derive estimates of effectiveness
The authors made assumptions to derive estimates of effectiveness.
Estimates of effectiveness and key assumptions
The authors assumed an increased risk of Caesarean delivery for multiparous women.
Measure of benefits used in the economic analysis
The summary measures of benefit used were the excess number of Caesarean deliveries and the decrease in foetal deaths after induction was performed, compared with the expectant labour management strategy. These measures of benefits were reported for all types of women considered at analysis (nulliparous and multiparous women, with either a favourable or an unfavourable cervix) at 39, 40 and 41 weeks' gestation. The measures were obtained from the model, and the results reported were incremental.
Direct costs
The direct costs considered in the economic analysis were those of the health service. These were associated with vaginal delivery, Caesarean delivery, the excess cost of induction resulting either in vaginal delivery or in Caesarean delivery for women with both favourable and unfavourable cervix, meconium aspiration syndrome, and antenatal testing. The resource quantities were not reported separately from the costs. The direct costs were obtained from published studies. Therefore, the costs were estimated on the basis of actual data.
The price year was 2001 and the costs were adjusted for inflation using the medical care component of the consumer price index. A cost-to-charge ratio of 0.6 was used to convert charge data to costs. Discounting was not performed, which was appropriate as the period considered for the economic evaluation was 4 weeks at maximum. The costs reported were mainly the incremental costs when induction was compared with expectant management, stratified by gestational age, parity and cervical ripeness.
The total costs of induction versus expectant management were only given for the hypothetical cohort of 100,000 nulliparous women with an unfavourable cervix at 39 weeks' gestation. The total costs were $503 million with induction and $412 million with expectant management.
The other reported costs were the incremental costs for 100,000 women managed with induction versus those managed with expectant management. The results were: $91 million (39 weeks), $71 million (40 weeks) and $39 million (41 weeks) for nulliparous women with an unfavourable cervix; $49 million (39 weeks), $48 million (40 weeks), and $29 million (41 weeks) for nulliparous women with a favourable cervix; $75 million (39 weeks), $58 million (40 weeks), and $26 million (41 weeks) for multiparous women with an unfavourable cervix; and $47 million (39 weeks), $42 million (40 weeks), and $25 million (41 weeks) for multiparous women with a favourable cervix.
Synthesis of costs and benefits
The costs and benefits were not combined. The results from the sensitivity analyses showed that the model was robust to the cost results obtained, and induction of labour was not cost-saving under any of the analyses performed.
